Table 32:
Deterministic Reference Case Analysis Results—Cost-Effectiveness of MRgFUS Neurosurgery Versus No Surgery
| MRgFUS Neurosurgery | No Surgery | |
|---|---|---|
| Cost of primary surgery | $19,786 | – |
| Cost of monitoring | $814 | $814 |
| Cost of medications | $1,095 | $1,245 |
| Cost of reoperation | $1,741 | – |
| Cost of managing adverse events | $71 | – |
| Total costs | $23,507 | $2,060 |
| Life-years | 4.63 | 4.63 |
| QALYs | 3.69 | 3.19 |
| Incremental cost | $21,448 | |
| Incremental life-years | 0.00 | |
| Incremental QALYs | 0.50 | |
| ICER (cost/QALY) | $43,075 | |
Abbreviations: ICER, incremental cost-effectiveness ratio; MRgFUS, magnetic resonance-guided focused ultrasound; QALY, quality-adjusted life-year.